In this study, the effects on paranoia and mechanisms of action of SlowMo, a digitally supported reasoning intervention, plus usual care compared with usual care only were investigated.
Specific cognitive deficits in childhood are distinctively associated with different mental health disorders, like borderline personality disorder, depression, and psychosis, in teens and young adults.
The sNDA submission was supported by data from the pivotal phase 3 HARMONY study.
The goal for this phase 2 trial was to assess the efficacy and safety of the combination oral agent xanomeline-trospium in patients with acute exacerbations of schizophrenia.
Researchers determined the prevalence of neuropsychiatric systemic lupus erythematosus in patients with psychosis with positive antinuclear antibodies.
ALKS 3831 is composed of samidorphan, a mu-opioid receptor antagonist, which is co-formulated with the established antipsychotic agent, olanzapine, in a single bilayer tablet.
This study investigates whether proteomic biomarkers may aid in the prediction of the transition to psychotic disorder in the clinical high-risk state and adolescent psychotic experiences in the general population.
Researchers conducted a systematic review and meta-analysis to assess the incidence and predictors of psychosis relapse in individuals receiving treatment with antipsychotic agents.
A retrospective study was conducted to evaluate the demographic predictors of ADHD in hospitalized children with ASD and the impact of comorbidities on length of stay.
Psychosis and BPD have previously been linked to persistent nightmares in childhood, and these findings highlight the importance of confronting sleep disturbances at young ages.
